Syncromune, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.syncromune.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 2
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- Procedure: Partial Oncolysis
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- Syncromune, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT06533644
- Locations
- 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States
🇺🇸Michigan Institute of Urology, Troy, Michigan, United States
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States
News
No news found